- Both Biden and Trump aim to lower drug prices to make healthcare more affordable, but Biden is expected to have a greater chance of success.
- We believe future healthcare policies are intertwined closely with the composition of the new Congress. A divided Congress may end up with little or no structural change and would be seen as largely positive for the healthcare sector.
- If a Blue Wave occurs, Biden’s ambition to remake the healthcare system may be more likely to pass. However, we believe that the near-term focus will still be on Covid-19 and any regulation or major changes may be put on hold until the worst of the crisis is over.
- We examine the impact on different healthcare industries under a Biden or Trump win. Below is a list of sector ETFs which investors may look out for.